NASDAQ
Genetic Technologies Limited (GENE) has a eps (diluted) of $-2.73 as of Sunday, June 30, 2024. Diluted EPS accounts for all potential shares from stock options and convertible securities, providing a more conservative earnings-per-share measure.
No price data available for this timeframe.